Skip to main content
Signal8

Ashe Carol Gail

SEC insider (Form 3/4/5 filer). CIK 0001761748. Director at Elicio Therapeutics, Inc. (ELTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in BOSTON, MA.

Companies Ashe Carol Gail has filed insider reports for

  • Elicio Therapeutics, Inc. (ELTX): Director
Ashe Carol Gail profile photo

Ashe Carol Gail

CIK: 0001761748

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Elicio Therapeutics, Inc. logo
ELTX

Elicio Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Elicio Therapeutics, Inc. logo
    ELTX

    Elicio Therapeutics, Inc.

    Aug 31, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    21.8K shares-
  • Elicio Therapeutics, Inc. logo
    ELTX

    Elicio Therapeutics, Inc.

    May 19, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    7.9K shares-
  • Elicio Therapeutics, Inc. logo
    ELTX

    Elicio Therapeutics, Inc.

    Nov 21, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    4.1K shares-

1-3 of 3